Advances in Flow Cytometry for Diagnostic Pathology

  • John S. Coon
  • Alan L. Landay
  • Ronald S. Weinstein

Abstract

Only 3 years have passed since Lovett et al. (147) first reviewed applications of flow cytometry (FCM) to diagnostic pathology in Laboratory Investigation. Progress in this field has been rapid, however, and the importance of having timely, practical knowledge of this technology has increased significantly for pathologists. Lovett’s lucid explanation of the basic function of the instrument would still be difficult to improve upon. Therefore, this review is not intended to duplicate or replace the earlier substantial monograph. Rather, we will attempt to update the reader on what we regard to be important recent developments in the field. We will also consider some older work which seems in retrospect, to have been insufficiently covered in Lovett’ review. Readers with little or no background in FCM may benefit from referring to the earlier review before starting this one, or else consulting other more comprehensive works, especially Shapiro’s monograph (204). For the many pathologists who have been following the development of FCM, we hope this review will aid in bringing advances in the state-of-the-art into perspective.

Keywords

Adenocarcinoma Bacillus Interferon Paraffin Sorting 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson J, Kelly M, Economou S, Jensik S, Williams J, Gebel H: Rejection of transplanted organs: a new method of detection. Fed Proc 46: 1357, 1987Google Scholar
  2. 2.
    Anderson KC, Boyd AW, Fisher DC, Leslie D, Schlossman SF, Nadler LM: Hairy cell leukemia: a tumor of preplasma cells. Blood 65: 620, 1985PubMedGoogle Scholar
  3. 3.
    Anderson KL, Bates MP, Slaugherhopt, Pinkus GS, Schlossman SF, Nadler LM: Expression of human B cell associated antigens on leukemia and lymphomas: a model of human B cell differentiation. Blood 63: 1424, 1984PubMedGoogle Scholar
  4. 4.
    Ault K, Antin J, Ginsburg D: Phenotype of recovering lymphoid cell population after bone marrow transplantation. J Exp Med 161: 1483, 1985PubMedGoogle Scholar
  5. 5.
    Ault KA, Springer TA: Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-mac-1) with human monocytes and natural killer cells. J Immunol 126: 359, 1981PubMedGoogle Scholar
  6. 6.
    Badalament RA, Gay H, Whitmore WF, Herr HW, Fair WR, Oettgen HF, Melamed MR: Monitoring intravesical Bacillus Cal-mette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry. Cancer 58: 2751, 1986PubMedGoogle Scholar
  7. 7.
    Baisch HB, Otto U, Klöppel G: Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis. Cytometry 7: 200, 1986PubMedGoogle Scholar
  8. 8.
    Bakhshi A, Minowada J, Anndd A, Cossman J, Jensen JP, Whang Peng J, Waldman TA, Korsmeyer SJ: Lymphoid blast crisis of chronic myelogenous leukemia represent stages in the development of B cell precursors. N Engl J Med 309: 826, 1983PubMedGoogle Scholar
  9. 9.
    Balch CM, Murad TM, Soong SJ, Ingalls AL, Halper NB, Maddox WA: A multifactorial analysis of melanoma: prognostic histopath-ological features comparing Clark’s and Breslow’s staging methods. Ann Surg 188: 732, 1978PubMedGoogle Scholar
  10. 10.
    Banner BF, Chacho MS, Roseman DL, Coon JS: Multiparameter flow cytometric analysis of colon polyps. Am J Clin Pathol 87: 313, 1987PubMedGoogle Scholar
  11. 11.
    Banner BF, Tomas-de la Vega JE, Roseman DL, Coon JS: Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma? Ann Surg 202: 740, 1985PubMedGoogle Scholar
  12. 12.
    Barlogie B, Alexanian R, Dixon D, Smith L, Smallwood L, Dela-salle K: Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood 66: 338, 1985PubMedGoogle Scholar
  13. 13.
    Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich EJ: Flow cytometry in clinical cancer research. Cancer Res 43: 3982, 1983PubMedGoogle Scholar
  14. 14.
    Bass DA, Pancre JW, DeChatelet LR, Szeda P, Seeds MC, Thomas MT: Flow cytometric studies of oxidative product formation by neutrophils. J Immunol 130: 190, 1983Google Scholar
  15. 15.
    Bassoe CF, Solsvik J, Laerum OD: Quantitation of single cell phagocytic capacity by flow cytometry. Flow Cytometry 4: 170, 1980Google Scholar
  16. 16.
    Bauer KD, Clevenger CV, Endow RK, Murad T, Epstein AL, Scarpelli DG: Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry. Cancer Res 46: 2428, 1986PubMedGoogle Scholar
  17. 17.
    Bauer KD, Merkel DE, Winter JN, Marder RJ, Hauck WW, Wallemark CB, Williams TJ, Variakojis D: Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res 46: 3173, 1986PubMedGoogle Scholar
  18. 18.
    Benson MC, McDougal DC, Coffey DS: The application of perpendicular and forward light scatter to assess nuclear and cellular morphology. Cytometry 5: 515, 1984PubMedGoogle Scholar
  19. 19.
    Benson MC, Walsh PC: The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer: preliminary results. J Urol 135: 1194, 1986PubMedGoogle Scholar
  20. 20.
    Bettelhein P, Lutz D, Majdin O, Paietta E, Haas O, Linkesch W, Neumann E, Lechner K, Krapp W: Cell lineage heterogeneity in blast crisis of chronic myeloid leukemia. Br J Haematol 59:395,1985Google Scholar
  21. 21.
    Bhan AK, Nadler LM, Stashenko P, McCluskey RT, Schlossman SF: Stages of B cell differentiation in human lymphoid tissue. J Exp Med 154: 757, 1981Google Scholar
  22. 22.
    Bijman JT, Wagener DJT, Wessels JMC, van den Broek P, Ramaekers FCS: Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry. Cytometry 7:76,1986PubMedGoogle Scholar
  23. 23.
    Binkley WF, Valenzuela R, Braun WE, Deodhar SD, Novick AC, Steinmuller DR: Flow cytometry quantitation of peripheral blood T-cell subsets in human renal allograft recipients. Transplant Proc 15: 1163, 1983Google Scholar
  24. 24.
    Boon ME, Auer GU, van Kaamnn H, Schwinghammer H: Classifying breast carcinomas with DNA measurements and morphometry. Cytometry 5: 469, 1984PubMedGoogle Scholar
  25. 25.
    Bowlby LS, DeBault LE, Abraham SR: Flow cytometric analysis of adrenal cortical tumor DNA: relationship between cellular DNA and histopathologic classification. Cancer 58: 1499, 1986PubMedGoogle Scholar
  26. 26.
    Broder J, Edelson RL, Lutzman MA, Nelson DL, MacDermott RP, Dunn ME, Goldman CK, Meade BD, Waldmann TA: The Sezary-syndrome: a malignant proliferation of helper T cells. J Clin Invest 58: 1297, 1976PubMedGoogle Scholar
  27. 27.
    Bruchner T, Hiddeman W, Nomann B, Kleinemeir B, Schumann J, Gohde W, Ritter J, Muller KM, von Bassewitz DB, Dressner A, Grundmann E: Differential pattern of DNA-aneuploidy in human malignancies. Pathol Res Pract 179: 310, 1985Google Scholar
  28. 28.
    Bunn PA, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MS, Blattner W, Broder S, Robert-Guroff M, Gallo RC: Clinical course of retrovirus associated adult T cell lymphoma in the United States. N Engl J Med 309: 257, 1983PubMedGoogle Scholar
  29. 29.
    Caligaris CF, Gobbi M, Boyill M, Janossy G: Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J Exp Med 155: 623, 1982Google Scholar
  30. 30.
    Carter NP, Cullen PR, Thompson JF, Bewick ALT, Wood RFM, Morris PJ: Monitoring lymphocyte subpopulations in renal allograft recipients. Transplant Proc 15: 1157, 1983Google Scholar
  31. 31.
    Casali P, Burastero SE, Nakamura M, Inghirani G, Notkins AL: Human lymphocytes making rheumatoid factor and antibody to single stranded DNA belong to Leu 1+ B cell subset. Science 236: 77, 1987PubMedGoogle Scholar
  32. 32.
    Chan LC, Pegram SM, Greaves MF: Contribution of immuno-phenotype to the classification and differential diagnosis of acute leukemia. Lancet 1: 475, 1985PubMedGoogle Scholar
  33. 33.
    Chang K, Enker WE, Melamed M: Influence of tumor cell DNA ploidy on the natural history of rectal cancer. Am J Surg 153:184,1987PubMedGoogle Scholar
  34. 34.
    Chessels JM, Hardisty RM, Rapson NT, Greaves MF: Acute lymphoblastic leukemia in children: classification and prognosis. Lancet 2: 1307, 1977Google Scholar
  35. 35.
    Chin JL, Huben RP, Nava E, Rustum YM, Greco JM, Pontes JE, Frankfurt OS: Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids. Cancer 56: 1677, 1985PubMedGoogle Scholar
  36. 36.
    Chin JL, Pontes JE, Frankfurt OS: Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J Urol 133: 582, 1985PubMedGoogle Scholar
  37. 37.
    Christensson B, Tribukait B, Linder IL, Ullman B, Biberfeld P: Cell proliferation and DNA content in non-Hodgkin’s lymphoma. Flow cytometry in relation to lymphoma classification. Cancer 58: 1295, 1986PubMedGoogle Scholar
  38. 38.
    Christov K: Flow cytometric DNA measurements in human thyroid tumors. Virchows Arch [B] 51: 255, 1986Google Scholar
  39. 39.
    Coles M, Rose M, Yacoub M: Appearance of cells bearing the Interleukin-2 receptor in peripheral blood of cardiac transplant patients and their correlation with rejection episodes. Transplant Proc 19: 2546, 1987PubMedGoogle Scholar
  40. 40.
    Collste LG, Darzynkiewicz Z, Traganos F, Sharpless TK, Sogani P, Grabstald H, Whitmore WF, Melamed MR: Flow cytometry in bladder cancer detection and evaluation using acridine orange metachromatic nucleic acid staining of irrigation cytology specimens. J Urol 123: 478, 1980PubMedGoogle Scholar
  41. 41.
    Colvin RB, Cosimi AB, Burton RC, Delmonico FL, Jaffers G, Rubin RH, Tolkoff-Rubin WE, Giorgi JV, McCluskey R, Russel PJ: Circulating T-cell subsets in 72 human renal allograft recipients: the OKT4+/OKT8+ cell ratio correlates with reversibility of graft injury and glomerulopathy. Transplant Proc 15: 1166, 1983Google Scholar
  42. 42.
    Colvin RB, Preffer FI: New technologies in cell analysis by flow cytometry. Arch Pathol Lab Med 111: 628, 1987PubMedGoogle Scholar
  43. 43.
    Coon JS, Bines S, Kheir S, Soong S: DNA flow cytometry in stage I cutaneous melanoma. Cytometry 1 (Suppl): 55, 1987Google Scholar
  44. 44.
    Coon JS, Deitch AD, deVere White RW, Koss LG, Melamed MR, Reeder JF, Weinstein RS: Interinstitutional variability in DNA flow cytometric analysis of tumors-the National Cancer Institute’s Flow Cytometry Network (NCI-FCN) experience. Cancer, in pressGoogle Scholar
  45. 45.
    Coon JS, Landay AL, Weinstein RS: Flow cytometric analysis of paraffin embedded tumors. Implications for diagnostic pathology. Human Pathol 117: 435, 1986Google Scholar
  46. 46.
    Coon JS, Schwartz D, Summers JL, Miller AW, Weinstein RS: Flow cytometry of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer 57: 1594, 1986PubMedGoogle Scholar
  47. 46.
    Coon JS, Schwartz D, Summers JL, Miller AW, Weinstein RS: Flow cytometry of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer 57: 1594, 1986PubMedGoogle Scholar
  48. 48.
    Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hanson WP, Delmonico FL, Russell P: Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal alografts. N Engl J Med 305: 308, 1981PubMedGoogle Scholar
  49. 49.
    Coulson PB, Thornthwaite JT, Wooley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res 44: 4187, 1984PubMedGoogle Scholar
  50. 50.
    Crist W, Boyett J, Roper M, Pullen J, Metzgar R, Van Eys J, Ragab A, Starling K, Viotti T, Cooper M: Pre B cell leukemia responds poorly to treatment: a pediatric oncology study group. Blood 63: 707, 1984Google Scholar
  51. 51.
    Czerniak B, Herz F, Wersto RP, Koss LG: Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells. Am J Pathol 126: 411, 1987PubMedGoogle Scholar
  52. 52.
    Czerniak B, Koss LG: Expression of Ca antigen on human urinary bladder tumors. Cancer 55: 2380, 1985PubMedGoogle Scholar
  53. 53.
    Czerniak B, Papenhausen PR, Herz F, Koss LG: Flow cytometric identification of cancer cells in effusions with Cal monoclonal antibody. Cancer 55: 2783, 1985PubMedGoogle Scholar
  54. 54.
    Damle NK, Engleman EG: Immunoregulatory T cells circuits in man: alloantigen-primed T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigen stimulus. J Exp Med 158: 159, 1983PubMedGoogle Scholar
  55. 55.
    Damle NK, Mohagheghpour N, Engleman EG: Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor-effector cells. J Immunol 132: 644, 1984PubMedGoogle Scholar
  56. 56.
    Damle NK, Mohagheghpour N, Hansen JA, Engleman EG: Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol 131: 2296, 1983PubMedGoogle Scholar
  57. 57.
    de Vere White RW, Olsson CA, Deitch AD: Flow cytometry: role in monitoring transitional cell carcinoma of bladder. Urology 28: 15, 1986Google Scholar
  58. 58.
    Divine M, Farcet JP, Gourdin MF, Tabilio A, Vasconcelos A, Andre C, Jouoult D, Bouguet J, Reyes F: Phenotype studies of fresh and cultured hairy cells with the use of immunologic markers and electron microscopy. Blood 64: 547, 1984PubMedGoogle Scholar
  59. 59.
    Douglass EC, Look AT, Webber B, Parham D, Wilimas JA, Green AA, Roberson PK: Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms’ tumor. J Clin Oncol 6: 975, 1986Google Scholar
  60. 60.
    Duque RE, Phan SH, Hudson JL, Till GO, Ward PA: Functional defects in phagocytic cells following thermal injury. Applications of flow cytometricanalysis. Am J Pathol 118: 116, 1985PubMedGoogle Scholar
  61. 61.
    Durie BGM, Grogan TM: CALLA-positive myeloma: An agressive subtype with poor survival. Blood 66: 229, 1985PubMedGoogle Scholar
  62. 62.
    Engleman EG, Berike C, Grumet FC, Evans RL: Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatability antigens. J Immunol 127: 2124, 1981PubMedGoogle Scholar
  63. 63.
    Engleman EG, Warnke R, Fox RI, Dilley J, Beniko CJ, Levy R: Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sei USA 78: 1791, 1981Google Scholar
  64. 64.
    Evans RL, Wall DW, Platsoucas CD, Siegal FP, Fikrig SM, Testa CM, Good RA: Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclona I antibodies to TH2 antigen. Proc Natl Acad Sei USA 78: 544, 1981Google Scholar
  65. 65.
    Farrow GM: Pathologist’s role in bladder cancer. Semin Oncol 6: 198, 1979PubMedGoogle Scholar
  66. 66.
    Farsund T, Hostmark JG, Laerum OD: Relation between flow cytometric DNA distribution and pathology in human bladder cancer. Cancer 54: 1771, 1984PubMedGoogle Scholar
  67. 67.
    Feitz WFJ, Beck HLM, Smeets AWGB, Debruyne FMJ, Vooijs GP, Herman CJ, Ramaekers FCS: Tissue-specific markers in flow cytometry of urological cancers: cytokeratins in bladder carcinoma. Int J Cancer 36: 349, 1985PubMedGoogle Scholar
  68. 68.
    Finan PJ, Quirke P, Dixon MF, Dyson JED, Giles GR, Bird CC: Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? Br J Cancer 54: 327, 1986PubMedGoogle Scholar
  69. 69.
    Foon KA, Billing RJ, Terasaki P, Cline MJ: Immunologic classification of acute lymphoblastic leukemmia: implications for normal lymphoid maturation. Blood 56: 1120, 1980PubMedGoogle Scholar
  70. 70.
    Foon KA, Billing RJ, Terasaki PI: Dual B and T markers in acute and chronic lymphocytic leukemia. Blood 55: 16, 1980PubMedGoogle Scholar
  71. 71.
    Fordham MVP, Burdge AH, Matthews J, Williams G, Cooke T: Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg 73: 400, 1986PubMedGoogle Scholar
  72. 72.
    Fossa SD, Pettersen EO, Thorud E, Melvik JE, Ous A: DNA flow cytometry in human testicular cancer. Cancer Lett 28: 55, 1985PubMedGoogle Scholar
  73. 73.
    Fossa SD, Thorud E, Pettersen EO, Shoaib MC, Scott-Knudsen O, Ous S: DNA flow cytometry in human bladder carcinoma. Pathol Res Pract 181: 291, 1986PubMedGoogle Scholar
  74. 74.
    Fozard JB, Quirke P, Dixon MF, Giles GR, Bird CC: DNA aneuploidy in ulcerative colitis. Gut 27: 1414, 1986PubMedGoogle Scholar
  75. 75.
    Frankfurt OS, Arbuck SG, Chin JL, Greco WR, Pavelic ZP, Slocum HK, Mittelman A, Piver SM, Pontes EJ, Rustum YM: Prognostic applications of DNA flow cytometry for human solid tumors. Ann NY Acad Sei 468: 276, 1986Google Scholar
  76. 76.
    Frankfurt OS, Greco WR, Slocum HK, Arbuck SG, Gamarra M, Pavelic ZP, Rustum YM: Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry. Cytometry 5: 6701, 1984Google Scholar
  77. 77.
    Frankfurt OS, Huben RP: Clinical applications of DNA flow cytometry for bladder tumors. Urology 23 (Suppl): 29, 1984PubMedGoogle Scholar
  78. 78.
    Freedman AS, Boyd AW, Anderson KC, Fisher DL, Pinkus GS, Schlossman SF, Nadler LM: Immunologic heterogeneity of diffuse large cell lymphomas. Blood 65: 630, 1985PubMedGoogle Scholar
  79. 79.
    Friedlander ML, Hedley DW, Taylor IW, Russell P, Coates AS, Tattersall MHN: Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 44: 397, 1984PubMedGoogle Scholar
  80. 80.
    Friedlander ML, Russell P, Taylor IW, Hedley DW, Tattersall MHN: Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology 16: 301, 1984PubMedGoogle Scholar
  81. 81.
    Gadol N, Ault KA: Phenotypic and functional characterization of human Leul (CD5) B cells. Immunol Rev 93: 24, 1986Google Scholar
  82. 82.
    Gansler T, Chatten J, Varello M, Bunin GR, Atkinson B: Flow cytometric DNA analysis of neuroblastoma. Cancer 58: 2453, 1986PubMedGoogle Scholar
  83. 83.
    Gatenby PA, Kansas GS, Xian C, Evans R, Englemann EG: Dissection of immunoregulating subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol 129: 1997, 1982Google Scholar
  84. 84.
    Gatenby PA, Kotzin BL, Engleman EG: Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper suppressor lymphocyte subsets defined by monoclonal antibodies. J Immunol 127: 2130, 1981PubMedGoogle Scholar
  85. 85.
    Gebel HM, Anderson JE, Gottschalk L, Bray RA: Determination of helper:suppressor T cell ratios. N Engl J Med 316: 113, 1987PubMedGoogle Scholar
  86. 86.
    Gebel HJ, Kaizer H, Landay AL: Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients. Transplantation 43: 258, 1987PubMedGoogle Scholar
  87. 87.
    Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB: Endometrial adenocarcinoma: a multiparameter clinicopath-ologic analysis including the DNA profile and the sex steroid hormone receptors. Cancer 58: 1518, 1986PubMedGoogle Scholar
  88. 88.
    Giorgi JV, Nishanian PG, Schmid I, Hultin LE, Cheng H, Detels R: Selective alterations in immunoregulatory lymphocyte subsets in early HIV (Human T-lymphotropic virus type III/Lymphade-nopathy associated-virus) infection. J Clin Immunol 7: 140, 1987PubMedGoogle Scholar
  89. 89.
    Glazer AN: Light harvesting by phycobilisomes. Ann Rev Biophys Chem 14: 4, 1985Google Scholar
  90. 90.
    Glazer AW: Phycobilisomes: structure and dynamics. Ann Rev Microbiol 36: 173, 1982Google Scholar
  91. 91.
    Glazer AW, Stryer L: Fluorescence tandem phycobiliprotein conjugates emission wavelength: shifting by energy transfer. Biophys J 43: 383, 1983PubMedGoogle Scholar
  92. 92.
    Goh HS, Jass JR: DNA content and the adenoma-carcinoma sequence in the colorectum. J Clin Pathol 39: 387, 1986PubMedGoogle Scholar
  93. 93.
    Gray JW: Monoclonal antibodies against bromodeoxyuridine. Cytometry 6: 499, 1985Google Scholar
  94. 94.
    Greaves MF, Brown G, Rapson NT, Lister TA: Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol 4: 67, 1975PubMedGoogle Scholar
  95. 95.
    Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV: Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67: 1, 1986PubMedGoogle Scholar
  96. 96.
    Greenebaum E, Koss LG, Elequin F, Silver CE: The diagnostic value of flow cytometric DNA measurements in follicular tumors of the thyroid gland. Cancer 56: 2011, 1985PubMedGoogle Scholar
  97. 97.
    Griffin JD, Tantravahi R, Canellos GP, Wisch SS, Reinherz EL, Sherwood G, Beveridge RP, Daley JF, Lane H, Schlossman SF: T cell surface antigen in a patient with blast crisis of chronic myeloid leukemia. Blood 61: 640, 1985Google Scholar
  98. 98.
    Gupta S: Subpopulations of CD4+ (T4+) cells in homosexual/bisexual men with persistant generalized lymphadenopathy. Clin Exp Immunol 68: 1, 1987PubMedGoogle Scholar
  99. 99.
    Gupta S, Pahwa R, O’Reilly R, Good RA, Siegel FP: Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sei USA 73: 919, 1976Google Scholar
  100. 100.
    Haas D, Feichter G, Gaerttler K, Kaufman M: Influence of systematic errors on the evaluation of the S phase portions from DNA distributions at solid tumors as shown for 328 breast carcinomas. Cytometry 8: 377, 1987Google Scholar
  101. 101.
    Hammarberg C, Slezak P, Tribukait B: Early detection of malignancy in ulcerative colitis. Cancer 53: 291, 1984PubMedGoogle Scholar
  102. 102.
    Haynes BF, Hersley LL, Jeyasothy BU: Phenotypic characterization of skin infiltrates T cells in cutaneous T cell lymphoma: Comparison with benign T cell infiltrates. Blood 60: 463, 1982PubMedGoogle Scholar
  103. 103.
    Hedley DW, Friedlander ML, Taylor IW: Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 6: 327, 1985PubMedGoogle Scholar
  104. 104.
    Hedley DW, Friedlander ML, Taylor JW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histo-chem Cytochera 31: 1333, 1983Google Scholar
  105. 105.
    Hedley DW, Rugg CA, Ng AB, Taylor IW: Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 44: 5395, 1984PubMedGoogle Scholar
  106. 106.
    Helio H, Karahaiju E, Nordling S: Flow cytometric determination of DNA content in malignant and benign bone tumours. Cytometry 6: 165, 1985PubMedGoogle Scholar
  107. 107.
    Herman CJ, McGraw TP, Marder RJ, Bauer KD: Recent progress in clinical quantitative cytology. Arch Pathol Lab Med 111: 505, 1987PubMedGoogle Scholar
  108. 108.
    Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA: Convention on nomenclature for DNA cytometry. Cytometry 5: 445, 1984Google Scholar
  109. 109.
    Hiddemann W, Wormann B, Ritter J, Thiel E, Gohde W, Lahme B, Henze G, Schellong G, Riehm, Buchner T: Frequency and clinical significance of DNA aneuploidy in acute leukemia. Ann NY Acad Sei 468: 227, 1986Google Scholar
  110. 110.
    Horan PK, Slezak S, Poste G: Improved flow cytometric analysis of leukocyte subsets: simultaneous identification of five cell subsets using two-color immunofluorescence. Proc Natl Acad Sei USA 83: 8361, 1986Google Scholar
  111. 111.
    Hoshinaga K, Mohanakumar T, Wood NL, Szentpetery S, Lower RR: Increase in transferrin receptors as a marker for rejection and infection in human cardiac transplantation. Transplant Proc 19: 2534, 1987PubMedGoogle Scholar
  112. 112.
    Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM: Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6: 627, 1985PubMedGoogle Scholar
  113. 113.
    Hostmark J, Vigander T, Skaarland E: Characterization of pleural effusions by flow-cytometric DNA analysis. Eur J Respir Dis 66: 315, 1985PubMedGoogle Scholar
  114. 114.
    Iversen OE: Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 155: 770, 1986PubMedGoogle Scholar
  115. 115.
    Jansen J, LeBien TW, Kersey JH: The phenotype of the neoplastic cells of hairy cell leukemia: studies with monoclonal antibodies. Blood 59: 609, 1982PubMedGoogle Scholar
  116. 116.
    Joensuu HI, Klemi P, Eerola L: DNA aneuploidy in follicular adenomas of the thyroid gland. Am J Pathol 124: 373, 1986PubMedGoogle Scholar
  117. 117.
    Johnson TS, Williamson KD, Cramer MM, Peters LJ: Flow cytometric analysis of head and neck carcinoma. DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading. Cytometry 6: 461, 1985PubMedGoogle Scholar
  118. 118.
    Kansas GS, Wood GS, Engleman EG: Maturational and functional diversity of human B lymphocytes delineated with anti- Leu-8. J Immunol 134: 3003, 1985PubMedGoogle Scholar
  119. 119.
    Kansas GS, Wood GS, Fishwild DM, Engleman EG: Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-Leu-8. J Immunol 134: 2995, 1985PubMedGoogle Scholar
  120. 120.
    Kaplan AS, Caldarelli DD, Cacho M, Bruce DR, Hutchinson J, Conway S, Coon JS: Retrospective DNA analysis of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 112: 1159, 1986PubMedGoogle Scholar
  121. 121.
    Kelly M, Gebel H, Williams J, Jensik S, Economou S, Anderson J: Immunologic rejection of a renal allograft: prediction with a new peripheral blood assay. Fed Proc 46: 1356, 1987Google Scholar
  122. 122.
    Kitchingham GR, Rovigatti U, Mauer AM, Melvin S, Murphy SB, Stass S: Rearrangement of immunoglobulin chain genes in T cell acute lymphoblastic leukemia. Blood 65: 725, 1985Google Scholar
  123. 123.
    Klein F, Whitmore W, Wolf R, Herr HW, Sogani P, Staiano-Coico L, Melamed MR: Presumptive down staging from preoperative irradiation for bladder cancer as determined by flow cytometry: a preliminary report. Int J Radiat Oncol Biol Phys 9: 487, 1983PubMedGoogle Scholar
  124. 124.
    Klein FA, Herr HW, Whitmore WF, Sogani PC, Melamed MR: An evaluation of automatic flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder. Cancer 50: 1003, 1982PubMedGoogle Scholar
  125. 125.
    Klein FA, Kay S, Ratliff JE, White FK, Newsome HH: Flow cytometric determinations of ploidy and proliferation patterns of adrenal neoplasms: an adjunct to histological classification. J Urol 134: 862, 1985PubMedGoogle Scholar
  126. 126.
    Kokal W, Sheibani K, Terz JJ, Harada JR: Tumor DNA content in the prognosis of colorectal carcinoma. J Am Med Assoc 255: 3123, 1986Google Scholar
  127. 127.
    Kokal WA, Duda RB, Azumi N, Sheibani K, Kemeny MM, Terz JJ, Harada JR: Tumor DNA content in primary and metastatic colorectal carcinoma. Arch Surg 121: 1434, 1986PubMedGoogle Scholar
  128. 128.
    Korsmeyer SJ, Arnold A, Bakhshi A, Ravetch JV, Sieberlist U, Hieter PA, Sharrow SO, LeBien TW, Kersey JH, Podlack DG, Leder P, Waldmann TA: Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leuke-mias of T cell and B cell precursor origins. J Clin Invest 71: 301, 1983PubMedGoogle Scholar
  129. 129.
    Korsmeyer SJ, Greene MC, Cossman J, Hsu SM, Jensen JP, Neckers LM, Marshall JL, Bakhshi A, Depper SM, Leonard WJ, Jaffe ES, Waldman TA: Rearrangement and expression of immunoglobulin genes and expression of TAC antigen in hairy cell leukemia. Proc Natl Acad Sei USA 80: 4522, 1983Google Scholar
  130. 130.
    Koss LG, Greenbaum E: Measuring DNA in human cancer. JAMA 255: 3158, 1986PubMedGoogle Scholar
  131. 131.
    Koziner B, Kempin S, Passe G, Gee T, Good RA, Clarkson BD: Characterization of B cell leukemias: a tentative immunomorpho-logical scheme. Blood 56: 815, 1980PubMedGoogle Scholar
  132. 132.
    Kreichbergs A, Tribukait B, Willems J, Bauer HCF: DNA flow cytometry of soft tissue tumors. Cancer 59: 128, 1987Google Scholar
  133. 133.
    Kung PC, Berger CL, Goldstein G, Longento P, Edelson RL: Cutaneous T cell lymphoma: characterization by monoclonal antibodies. Blood 57: 261, 1981PubMedGoogle Scholar
  134. 134.
    Landay A, Gartland GL, Clemant L: Characterization of a phe-notypically distinct subpopulation of Leu 2+ cells which suppress T cell proliferative responses. J Immunol 131: 2757, 1983PubMedGoogle Scholar
  135. 135.
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH: The relationship of CD16 (Leull) and Leul9 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136: 4480, 1986PubMedGoogle Scholar
  136. 136.
    Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF, Kay HD, Smith DL, Sullivan G, Mandell GL, Donowitz GR: Subpop-ulations of human natural killer cells defined by expression of the Leu7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 131: 1789, 1983PubMedGoogle Scholar
  137. 137.
    Lanier LL, Philips JH: A map of the cell surface antigens expressed on resting and activated human natural killer cells. In Leukocyte Typing II, edited by Reinherz RL, Haynes BF, Nadler LM, Bernstein ID, p 57. New York, Springer Verlag, 1985Google Scholar
  138. 138.
    Ligler FS, Kettman JR, Smith G, Frenkel EP: Immunoglobulin phenotype on B cells correlates with clinical stage of chronic lymphocytic leukemia. Blood 62: 256, 1983PubMedGoogle Scholar
  139. 139.
    Link M, Warnke R, Finlay D, Amylon M, Miller R, Dilley J, Levy R: A single monoclonal antibody identifies T cell lineage of childhood lymphoid malignancies. Blood 2: 722, 1983Google Scholar
  140. 140.
    Linker-Israeli M, Bakke A, Quismonio F, Horwitz D: Correction of interluekin 2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clinical Invest 75: 762, 1985Google Scholar
  141. 141.
    Loken MR: Simultaneous quantitation of Hoechst 33342 and immunofluorescence on viable cells using a fluorescence activated cell sorter. Cytometry 1: 136, 1980PubMedGoogle Scholar
  142. 142.
    Loken MR, Keij JF, Kelley KA: Comparison of helium-neon and dye lasers for the excitation of allophycocyanin. Cytometry 8: 96, 1987PubMedGoogle Scholar
  143. 143.
    Loken MR, Lanier L: Three-color immunofluorescence analysis of Leu antigens on human peripheral blood using two lasers on a fluorescence activated cell sorter. Cytometry 5: 151, 1984PubMedGoogle Scholar
  144. 144.
    Loken MR, Parks DR, Herzenberg LA: Two-color immunofluorescence using a fluorescence activated cell sorter. J Histochem Cytochem 25: 899, 1977PubMedGoogle Scholar
  145. 145.
    Loken MR, Stall AM: Flow cytometry as an analytical and preparative tool in immunology. J Immunol Methods 50: R85, 1982PubMedGoogle Scholar
  146. 146.
    Look AT, Melvin SL, Williams DL, Brodeur GM, Dahl GV, Kalwinsky DK, Murphy SB, Mauer AM: Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood 60: 959, 1982PubMedGoogle Scholar
  147. 147.
    Lovett EJ, Schnitzer B, Keren DF, Flint A, Hudson JL, McClatchey KD: Application of flow cytometry to diagnostic pathology. Lab Invest 50: 115, 1984PubMedGoogle Scholar
  148. 148.
    Luce G, Sharrow S, Shaw S, Gallop P: Enumeration of cytotoxic cell target cell conjugates by flow cytometry using internal fluorescent stains. Biofeedback Self Regul 3: 370, 1985Google Scholar
  149. 149.
    Lungu O, Reed E, Smith C, Rose E, Marboe C, Hardy M, Reemtsma K, Fenoglio J, Suciu-Foca N: Immunologic monitoring of heart allograft recipients. Transplant Proc 19: 2548, 1987PubMedGoogle Scholar
  150. 150.
    Lydyard PM, Youinou PY, Cooke A: CD5 positive B cells in rheumatoid arthritis and chronic lymphocytic leukemia. Immunol Today 8: 371, 1986Google Scholar
  151. 151.
    Macartney JC, Camplejohn RS, Powell G: DNA flow cytometry of histological material from human gastric cancer. J Pathol 148: 273, 1986PubMedGoogle Scholar
  152. 152.
    Mankin HJ, Connor JF, Schiller AL, Perlmutter N, Alho A, McGuire M: Grading of bone tumors by analysis of nuclear DNA content using flow cytometry. J Bone Joint Surg 67: 404, 1985PubMedGoogle Scholar
  153. 153.
    Mauro F, Teodori L, Schumann J, Gohde W: Flow cytometry as a tool for the prognostic assessment of human neoplasa. Int J Radiat Oncol Biol Phys 12: 625, 1986PubMedGoogle Scholar
  154. 154.
    McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC: A proposed classification of breast cancer based on kinetic information. Cancer 57: 269, 1986PubMedGoogle Scholar
  155. 155.
    McGuire WL, Meyer JS, Barlosie B, Kute TE: Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat 5: 117, 1985PubMedGoogle Scholar
  156. 156.
    Mclntire TL, Murphy WM, Coon JS, Chandler RW, Schwartz D, Conway S, Weinstein RS: The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland. Am J Clin Pathol, in PressGoogle Scholar
  157. 157.
    McKinley M, Budman D, Caccese W, Weissman G, Scheidt N, Kahn E, Bronzo R: Evaluation of colonic neoplasia by flow cytometry of endoscopic biopsies. Am J Gastroenterol 80: 47, 1985PubMedGoogle Scholar
  158. 158.
    Melamed MR, Enker WE, Banner P, Janor AJ, Kessler G, DarzynKiewicz Z: Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum 29: 184, 1986PubMedGoogle Scholar
  159. 159.
    Melamed MR, Klein FA. Flow cytometry of urinary bladder irrigation specimens. Human Pathol 15: 302, 1984Google Scholar
  160. 160.
    Mellin W, Roessner A, Grundmann E, Wormann B, Hiddemann W, Immenkamp M: Biological characterization of human bone tumors. VII. Detection of malignancy in a giant cell tumor of bone by flow cytometric DNA analysis. Pathol Res Pract 180: 619, 1985PubMedGoogle Scholar
  161. 161.
    Moran RE, Melamed MR: Flow cytometric analysis of human lung cancer; correlation with histologic type and stage. Analyt Quant Cytol 6: 99, 1984Google Scholar
  162. 162.
    Morimoto C, Letvin N, Boyd A, Hagan M, Brown H, Kornacki M, Schlossman SF: The isolation and characterization of the human helper inducer cell subset. J Immunol 134: 3762, 1985PubMedGoogle Scholar
  163. 163.
    Morimoto C, Letvin N, Distaso J, Aldrich W, Schlossman SF: The isolation and characterization of the human suppressor inducer T cells subset. J Immunol 134: 1508, 1985PubMedGoogle Scholar
  164. 164.
    Murphy WM, Chandler RW, Trafford RM: Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas. J Urol 135: 694, 1986PubMedGoogle Scholar
  165. 165.
    Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, Soloway MS: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 136: 815, 1986PubMedGoogle Scholar
  166. 166.
    Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF: B4, a human B lymphocyte associated antigen expressed on normal mitogen activate and malignant B lymphocytes. J Immunol 134: 2228, 1985PubMedGoogle Scholar
  167. 167.
    Nadler LM, Korsmeyer SJ, Anderson KC, Boyd AU, Slaugherhaupt B, Park E, Jenson J, Coral F, Meyer FJ, Sallar SE, Ritz J, Schlossman SF: B cell origin of non-T cell acute lymphoblastic leukemia: a model for discrete stages of neoplastic and normal pre B cell differentiation. J Clin Invest 74: 332, 1984PubMedGoogle Scholar
  168. 168.
    Nicholson JKA, Jones BM, Echenberg DN, Spira TJ, McDougal S: Phenotypic distribution of T cells of patients who have subsequently developed AIDS. Clin Immunol Immunopathol 43: 82, 1987PubMedGoogle Scholar
  169. 169.
    The non-Hodgkin’s lymphoma pathologic classification project, National Cancer Institute sponsored study of the classification of non-Hodgkin’s lymphoma survey and description of a working formalization for clinical usage. Cancer 49: 2112, 1982Google Scholar
  170. 170.
    Oi VT, Glaser AW, Stryer L: Fluorescent phycobiliprotein conjugates for analyses of cells and molecules. J Cell Biol 93: 981, 1982PubMedGoogle Scholar
  171. 171.
    Oosterhuis JW, deJong B, Cornelisse CJ, Molenaar IM, Meiring A, Idenburg V, Koops HS, Sleijfer DT: Karyotyping and DNA flow cytometry of mature residual teratoma after intensive chemotherapy of disseminated nonseminomatous germ cell tumor of the testis: a report of two cases. Cancer Genet Cytogent 22: 149, 1986Google Scholar
  172. 172.
    Ortaldo JR, Sharrow SO, Timonen T, Herberman RB: Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol 127: 2401, 1981PubMedGoogle Scholar
  173. 173.
    O’Tolle CM, Maber P, Spiegelhalter DJ, Walker JR, Stovin P, Wallwork J, English TAH: “Rejection of Infection” predictive value of T-cell subset ratio, before and after heart transplantation. Heart Transplant 4: 518, 1985Google Scholar
  174. 174.
    Oud PS, Hanselaar TGJM, Reubsaet-Veldhuizen JAM, Meijer JWR, Gemmink AH, Pahlplatz MMM, Beck HVM, Vooijs GP: Extraction of nuclei from selected regions in paraffin embedded tissue. Cytometry 7: 595, 1986PubMedGoogle Scholar
  175. 175.
    Oud PS, Henderik JBJ, Beck HLM, Veldhuizen JAM, Vooijs GP, Herman CJ, Ramaekers FCS: Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labeling for cytokeratin using a monoclonal antibody. Cytometry 6:159,1985PubMedGoogle Scholar
  176. 176.
    Pearl ER, Vogler LB, Okos AJ, Crist WM, Lawton AR III, Cooper MD: B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody deficient states. J Immunol 120: 1169, 1978PubMedGoogle Scholar
  177. 177.
    Perussia B, Stann S, Abraham S, Fanning V, Trinchieri G: Human natural killer cells analyzed by B73.1, A monoclonal antibody blocking Fc receptor function. J Immunol 130: 2133, 1983PubMedGoogle Scholar
  178. 178.
    Perussia B, Trinchieri G: Antibody 3G8, specific for the human neutrophil Fc receptor reacts with natural killer cells. J Immunol 132: 1410, 1984PubMedGoogle Scholar
  179. 179.
    Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rum-pold H, Kraft D, Lanier LL: The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol 133: 180, 1984PubMedGoogle Scholar
  180. 180.
    Phillips JH, Warner W, Lanier LL: Correlation of biophysical properties and cell surface antigenic profile of percoll gradient-separated human natural killer cells. Nat Immun Cell Growth Regul 3: 73, 1984Google Scholar
  181. 181.
    Quirke P, Dyson JED: Flow cytometry: Methodology and applications in pathology. J Pathol 149: 79, 1986PubMedGoogle Scholar
  182. 182.
    Robinovitch PS, Torres RM, Engel D: Simultaneous cell cycle analysis and two-color surface immunofluorescences using 7 amino-actinomycin D and single laser excitation: applications to study of cell activation and the cell cycle of murine LY-1 B cells. Immunology 136: 2769, 1986Google Scholar
  183. 183.
    Rappaport H: Tumors of the hematopoeitic system. In Atlas of Tumor Pathology, Section B fascile 8, Washington DC, US Armed Forces Institute of Pathology, 1966Google Scholar
  184. 184.
    Raza A, Ucar K, Preisler HD: Double labeling and in vitro vs in vitro incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia. Cytometry 6: 633, 1985PubMedGoogle Scholar
  185. 185.
    Redner A, Melamed MR, Andreeff M: Detection of central nervous system relapse in acute leukemia by multiparameter flow cytometry of DNA, RNA, and CALLA. Ann NY Acad Sei 468:241,1986Google Scholar
  186. 186.
    Reinherz EL, Cooper MD, Schlossman SF, Rosen FS: Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. J Clin Invest 68: 699, 1981PubMedGoogle Scholar
  187. 187.
    Reinherz EL, Morimoto C, Fitzgerald K, Hussey RE, Daley J, Schlossman SF: Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol 128: 463, 1982PubMedGoogle Scholar
  188. 188.
    Reinherz EL, Rubenstein AJ, Geha RS, Stel Kaukas AJ, Rosen FS, Schlossman SF: Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med 301: 1018, 1979PubMedGoogle Scholar
  189. 189.
    Reinherz EL, Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19: 821, 1980PubMedGoogle Scholar
  190. 190.
    Reynolds CW, Foon KA: Ty lymphoproliferative disease and related disorders in man and experimental animals: a review of the clinical cellular and functional characterization. Blood 64: 1146, 1984PubMedGoogle Scholar
  191. 191.
    Roodman ST, Miller LW, Tsai C, Pennington DG, Kanter K, McBride L: Interleukin-2 receptors (IL2R) on T4 cells in cardiac transplantation. Fed Proc 46: 1356, 1987Google Scholar
  192. 192.
    Ross GD, Polky MS: Specificity of human lymphocyte complement receptors. J Exp Med 141: 1163, 1975PubMedGoogle Scholar
  193. 193.
    Royer HD, Acuto O, Fabbi M, Tizard R, Ramachardrin K, Smart JE, Reinherz EL: Genes encoding the Tiß subunit of the antigen MHC receptor undergo rearrangement during intrathymic ontogeny prior to surface T3-Ti expression. Cell 39: 266, 1984Google Scholar
  194. 194.
    Rubartelli A, Sitia R, Zicca A, Grossi CE, Ferrarini M: Differentiation of chronic lymphocytic leukemia cells: Correlation between the synthesis and secretion of immunoglobulins and the ultra-structure of the malignant cells. Blood 62: 495, 1983PubMedGoogle Scholar
  195. 195.
    Rudenburg CJ, Cornelisse CJ, Heintz PAM, Hermans J, Fleuren GJ: Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer 59: 317, 1987Google Scholar
  196. 196.
    Rumpold H, Kraft D, Obexer G, Bock G, Gebhart W: A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes. J Immunol 129: 1458, 1982PubMedGoogle Scholar
  197. 197.
    Ryan DH, Mitchell SJ, Hennessy LA, Bauer KD, Horan PK, Cohen HJ: Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry. J Immunol Methods 74: 115, 1984PubMedGoogle Scholar
  198. 198.
    Schrott RW, Foon KA, Billing RJ, Fahey JL: Immunologic classification of lymphocytic leukemia based on monoclonal antibody defined cell surface antigens. Blood 59: 207, 1982Google Scholar
  199. 199.
    Schwartz D, Banner BF, Roseman DL, Coon JS: Multiple “primary” colon carcinomas: A retrospective flow cytometric study. Cancer 58: 2082, 1986PubMedGoogle Scholar
  200. 200.
    Scott NA, Grande JP, Weiland LH, Pemberton JH, Beart RW, Lieber MM: Flow cytometric DNA patterns from colorectal cancer—how reproducible are they? Mayo Clin Proc 62: 331, 1987PubMedGoogle Scholar
  201. 201.
    Seligmann B, Gallin JO: Use of lipophilic probes of membrane potential to assess human neutrophil activation: abnormality in chronic granulomatous disease. J Clin Invest 66: 493, 1980PubMedGoogle Scholar
  202. 202.
    Shapiro HM: Laser noise and news. Cytometry 8: 248, 1987PubMedGoogle Scholar
  203. 203.
    Shapiro HM: Multistation multiparameter flow cytometry: a critical review and rationale. Cytometry 3: 227, 1983PubMedGoogle Scholar
  204. 204.
    Shapiro HM: Practical Flow Cytometry. New York, Alan R. Liss, 1985Google Scholar
  205. 205.
    Shapiro HM: Technical developments in flow cytometry. Hum Pathol 17: 649, 1986PubMedGoogle Scholar
  206. 206.
    Shapiro HM, Hercher M: Flow cytometers using optical wave guides in place of lenses for specimen illumination and light collection. Cytometry 7: 221, 1986PubMedGoogle Scholar
  207. 207.
    Shaw S: Characterization of human leukocyte differentiation antigens. Immunol Today 167: 1, 1987Google Scholar
  208. 208.
    Shen SY, Weir MR, Kosenko A, Revie DR, Ordonez JV, Dagher FJ, Chretien P, Sadler JH: Réévaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients. Transplantation 40: 620, 1985PubMedGoogle Scholar
  209. 209.
    Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield CD: Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316: 1111, 1987PubMedGoogle Scholar
  210. 210.
    Sobol RE, Royston I, LeBien TW, Minowada J, Anderson C, Ellison RR, Bloomfield CD: Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 65: 730, 1985PubMedGoogle Scholar
  211. 211.
    Sondergaard K, Larsen JK, Muller U, Christiansen IJ, Hou-Jensen K: DNA ploidy characteristics of human malignant melanoma analyzed by flow cytometry and compared with the clinical course. Virchows Arch [B] 42: 43, 1983Google Scholar
  212. 212.
    Spaar FW, Ahyai A, Spaar U, Gazso L, Zimmermann A: Flow cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro. Clin Neuropathol 5: 157, 1986PubMedGoogle Scholar
  213. 213.
    Steinkamp JA, Wilson JS, Saunders GC, Stewart CC: Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science 215: 64, 1982PubMedGoogle Scholar
  214. 214.
    Stelzer GT, McLeish KR, Londen RE, Watson SL: Alterations in T lymphocyte subpopulations associated with renal allograft rejection. Transplantation 37: 261, 1984PubMedGoogle Scholar
  215. 215.
    Stephenson RA, Gay H, Fair WR, Melamed MR: Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissues. Cytometry 7: 41, 1986PubMedGoogle Scholar
  216. 216.
    Stites DP, Casavant CH, McHugh TM, Moss AR, Beal JL, Ziegler JL, Saunders AM, Warner NL: Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence. Clinical Immunol Im-munopathol 38: 161, 1986Google Scholar
  217. 217.
    Stohl W, Crow MK, Kunkel HG: Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells. N Engl J Med 312: 1671, 1985PubMedGoogle Scholar
  218. 218.
    Suarez C, Miller DR, Steinherz PG, Melamed MR, Andreeff M: DNA and RNA determination in 111 cases of childhood acute lymphoblastic leukaemia (ALL) by flow cytometry: correlation of FAB classification with DNA stemline and proliferation. Br J Haematol 60: 677–86, 1985PubMedGoogle Scholar
  219. 219.
    Summers JL, Coon JS, Ward RM, Weinstein RS: Prognosis in carcinoma of the urinary bladder based upon tissue ABH and T antigen status and karyotype of the initial tumor. Cancer Res 43: 934, 1983PubMedGoogle Scholar
  220. 220.
    Tawa A, Hozumi N, Mindor M, Mak TW, Gelfand EW: Rearrangement of the T cell receptor ß chain gene in non-T cell non-B cell acute lymphoblastic leukemia of childhood. N Engl J Med 313: 1033, 1985PubMedGoogle Scholar
  221. 221.
    Terynck T, Dighiero G, Follezou J, Binet JL: Comparison of normal and CLL lymphocyte surface Ig determinants using peroxidase labeled antibodies. I. Detection and quantitation of light chain determinant. Blood 43: 79, 1974Google Scholar
  222. 222.
    Thorud E, Fossa SD, Vaage S, Kaalhus O, Knudson OS, Bormer O, Shoaib MC: Primary breast cancer: Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer 57: 808, 1986PubMedGoogle Scholar
  223. 223.
    Torok-Storb B, Doney K, Sale G, Thomas ED, Storb R: Subsets of patients with aplastic anemia identified by flow microfluorometry. N Engl J Med 312: 1015, 1985PubMedGoogle Scholar
  224. 224.
    Tsudo M, Uchiyama T, Uchino H, Yodoid J: Failure of regulation of TAC antigen TCGF receptor in adult T cell leukemia cells by the anti TAC monoclonal antibody. Blood 62: 1014, 1983Google Scholar
  225. 225.
    Tsukimoto I, Wong KY, Lumpkin BC: Surface markers as prognostic factors in childhood acute leukemia. N Engl J Med 292: 828, 1975Google Scholar
  226. 226.
    Tsushima K, Rainwater LM, Goellner JR, Heerden JA, Lieber MM: Leiomyosarcomas and benign smooth muscle tumors of the stomach: nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 62: 275, 1987PubMedGoogle Scholar
  227. 227.
    Valet G, Russmann L, Wirsching R: Automated flow-cytometric identification of colo-rectal tumour cells by simultaneous DNA, CEA-antibody, and cell volume measurements. J Clin Chem Clin Biochem 22: 935, 1984PubMedGoogle Scholar
  228. 228.
    van den Ingh HF, Griffioen G, Cornelisse CJ: Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res 45: 3392, 1985PubMedGoogle Scholar
  229. 229.
    van Driel-Kulker AMJ, Eysackers MJ, Dessing MTM, Ploem JS: A simple method to select specific tumor areas in paraffin blocks using incident fluorescence microscopy. Cytometry 7: 601, 1986PubMedGoogle Scholar
  230. 230.
    van Es A, Baldwin WM, Oljans PJ, Tanke HJ, Ploem JS, van Es LA: Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft rejection episodes and cytomegalovirus infection. Transplantation 37: 65, 1984PubMedGoogle Scholar
  231. 231.
    van Es A, Tanke HJ, Baldwin WM, Oljans PJ, Ploem JS, van Es LA: Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy. Clin Exp Immunol 52: 13, 1983PubMedGoogle Scholar
  232. 232.
    Vindelov LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323, 1983PubMedGoogle Scholar
  233. 233.
    Vogler LB, Christ WM, Bockman DE, Pearl ER, Lawton AR, Cooper MD: Pre B cell leukemia. A new phenotype of childhood lymphoblastic leukemia. N Engl J Med 298: 972, 1978Google Scholar
  234. 234.
    Volm M, Drings P, Mattern J, Sonka J, Vogt-Moykopf I, Wayss K: Relevance of DNA-fluorimetry and short-term resistance testing for adjuvant treatment of non-small cell lung carcinoma. Anticancer Res 6: 931, 1986PubMedGoogle Scholar
  235. 235.
    Volm M, Mattem J, Sonka J, Vogt-Schaden M, Wayss K: DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry 6: 348, 1985PubMedGoogle Scholar
  236. 236.
    Von Roenn J, Kheir S, Wolter J, Coon JS: Significance of DNA abnormalities in primary malignant melanoma and nevi, a retro-spective flow cytometric study. Cancer Res 46: 3192, 1986Google Scholar
  237. 237.
    Waldmann TA, Dürrn M, Brador J, Blackman M, Blaese RM, Strober W: Role of suppressor T cells in the pathogensis of common variable hypogammaglobulimenia. Lancet ii: 609, 1974Google Scholar
  238. 238.
    Watson JV: Oncogenes, cancer, and analytical cytology. Cytometry 7: 400, 1986PubMedGoogle Scholar
  239. 239.
    Watson JV, Sikora K, Evan GI: A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material. J Immunol Methods 83: 179, 1985PubMedGoogle Scholar
  240. 240.
    Waymouth C: Methods for obtaining cells in suspension from animal tissues. In Cell Separation Methods and Selected Application, edited by Pretlow TG, Pretlow TP, pp 1–29. New York, Academic Press, 1982Google Scholar
  241. 241.
    Weinstein RS, Schwartz D, Coon JS: Blood group antigens and ploidy as prognostic factors in urinary bladder carcinoma. In New Concepts in Neoplasm as Applied to Diagnostic Pathology, edited by Fenoglio-Preiser CM, Weinstein RS, Kaufman N, pp 225–241. Baltimore, Williams & Wilkins, 1986Google Scholar
  242. 242.
    Weiss H, Wildner GP, Jacobasch KH, Heinz U, Schaelicke W: Characterization of human adenomatous polyps of the colorectal bowel by means of DNA distribution patterns. Oncology 42: 33, 1985PubMedGoogle Scholar
  243. 243.
    Williams JM, Loeutscher R, Cotner T, Reddish M, Shapiro HM, Carpenter CB, Strominger JL, Strom TB: Dual parameter flow cytometric analysis of DNA content activation antigen expression and T cell subset proliferation in the human mixed lymphocyte reaction. J Immunol 132: 2330, 1984PubMedGoogle Scholar
  244. 244.
    Williams NS, Durdey P, Quirke P, Robinson PJ, Dyson JED, Dixon MF, Bird CC: Preoperative staging of rectal neoplasm and its impact on clinical management. Br J Surg 72: 868, 1985PubMedGoogle Scholar
  245. 245.
    Wolly RC, Schreiber K, Koss LG, Karas M, Sherman A: DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 69: 15, 1982Google Scholar
  246. 246.
    Zarcone D, Tilden A, Cloud JG, Friedman H, Landay A, Grossi C: Flow cytometry evaluation of cell mediated cytotoxicity. J Immunol Methods 94: 747, 1986Google Scholar
  247. 247.
    Zoumbos NC, Gascon P, Djeu J, Trost S, Young N: Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312: 257, 1985PubMedGoogle Scholar

Copyright information

© Humana Press · Clifton, New Jersey 1989

Authors and Affiliations

  • John S. Coon
    • 1
    • 2
  • Alan L. Landay
    • 1
  • Ronald S. Weinstein
    • 1
  1. 1.Department of Pathology and Immunology/MicrobiologyRush Medical College and Rush-PresbyterianSt. Luke’s Medical CenterChicagoUSA
  2. 2.Department of PathologyRush-Presbyterian-St. Luke’s Medical CenterChicagoUSA

Personalised recommendations